<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Advances in medicine &#187; HIV</title>
	<atom:link href="http://www.advances-in-medicine.com/category/hiv/feed" rel="self" type="application/rss+xml" />
	<link>http://www.advances-in-medicine.com</link>
	<description></description>
	<lastBuildDate>Thu, 02 Feb 2012 18:12:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Antiretroviral Therapy in HIV-infected Adults: Lipodystrophy and Metabolic Complications</title>
		<link>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-lipodystrophy-and-metabolic-complications.html</link>
		<comments>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-lipodystrophy-and-metabolic-complications.html#comments</comments>
		<pubDate>Sun, 13 Jun 2010 16:14:02 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[HIV]]></category>
		<category><![CDATA[Adults]]></category>
		<category><![CDATA[Antiretroviral Therapy]]></category>
		<category><![CDATA[HIV-infected]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1891</guid>
		<description><![CDATA[The lipodystrophy and metabolic complications that can arise during HAART have not been conclusively associated with one particular drug class or therapeutic agent, although some agents have been implicated more frequently. In fact, in July 2001, the FDA&#8217;s Division of Antiviral Drug Products wrote to all manufacturers of antiretroviral drugs and required that they include [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-lipodystrophy-and-metabolic-complications.html/feed</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Antiretroviral Therapy in HIV-infected Adults: Resistance Testing</title>
		<link>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-resistance-testing.html</link>
		<comments>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-resistance-testing.html#comments</comments>
		<pubDate>Sat, 12 Jun 2010 16:14:01 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[HIV]]></category>
		<category><![CDATA[Adults]]></category>
		<category><![CDATA[Antiretroviral Therapy]]></category>
		<category><![CDATA[HIV-infected]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1890</guid>
		<description><![CDATA[Resistance to HAART therapy has been a major obstacle in the long-term management of HIV infection. Increasingly, to guide drug selection, clinicians are testing for HIV resistance to antiretroviral agents as well as assessing patients&#8217; detailed drug histories. This testing can use either genotypic or phe-notypic methods to determine whether patients have HIV mutations that [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-resistance-testing.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antiretroviral Therapy in HIV-infected Adults: Adherence to Therapy</title>
		<link>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-adherence-to-therapy.html</link>
		<comments>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-adherence-to-therapy.html#comments</comments>
		<pubDate>Fri, 11 Jun 2010 16:14:01 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[HIV]]></category>
		<category><![CDATA[Adults]]></category>
		<category><![CDATA[Antiretroviral Therapy]]></category>
		<category><![CDATA[HIV-infected]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1889</guid>
		<description><![CDATA[Many studies have cited an association between poor adherence and incomplete viral suppression. In one study, 84 patients were assessed after six months of antiretroviral therapy. A significant association was observed between adherence and virological suppression (P &#60; .001). The authors concluded that a high level of adherence to therapy was important for virological success; [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-adherence-to-therapy.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antiretroviral Therapy in HIV-infected Adults: Therapeutic Review: Background</title>
		<link>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-therapeutic-review-background.html</link>
		<comments>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-therapeutic-review-background.html#comments</comments>
		<pubDate>Thu, 10 Jun 2010 16:14:00 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[HIV]]></category>
		<category><![CDATA[Adults]]></category>
		<category><![CDATA[Antiretroviral Therapy]]></category>
		<category><![CDATA[HIV-infected]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1888</guid>
		<description><![CDATA[On February 4, 2002, guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, developed by the Panel on Clinical Practices for Treatment of HIV Infection of the Department of Health and Human Services (DHHS), were revised. A panel subcommittee reviews and updates these guidelines each month (see the AIDS Web site). Experts [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults-therapeutic-review-background.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Antiretroviral Therapy in HIV-infected Adults</title>
		<link>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults.html</link>
		<comments>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults.html#comments</comments>
		<pubDate>Wed, 09 Jun 2010 16:44:10 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[HIV]]></category>
		<category><![CDATA[Adults]]></category>
		<category><![CDATA[Antiretroviral Therapy]]></category>
		<category><![CDATA[HIV-infected]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1887</guid>
		<description><![CDATA[Overview Although the prevalence of acquired immunodeficiency syndrome (AIDS) in the U.S. continues to rise, there has been a concomitant decrease in AIDS-related morbidity and mortality as a result of advances in antiretroviral therapy. The efficient use of resources is necessary to ensure optimal patient care. To minimize the potential for developing resistance, initial antiretroviral [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2010/06/antiretroviral-therapy-in-hiv-infected-adults.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HEMOGLOBINOPATHY AND PATTERN OF MUSCULOSKELETAL INFECTION IN CHILDREN: Results</title>
		<link>http://www.advances-in-medicine.com/2009/12/hemoglobinopathy-and-pattern-of-musculoskeletal-infection-in-children-results.html</link>
		<comments>http://www.advances-in-medicine.com/2009/12/hemoglobinopathy-and-pattern-of-musculoskeletal-infection-in-children-results.html#comments</comments>
		<pubDate>Wed, 09 Dec 2009 08:29:52 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[HIV]]></category>
		<category><![CDATA[bacteria]]></category>
		<category><![CDATA[Children]]></category>
		<category><![CDATA[hemoglobinopathy]]></category>
		<category><![CDATA[infection]]></category>
		<category><![CDATA[osteomyelitis]]></category>
		<category><![CDATA[pyomyositis]]></category>
		<category><![CDATA[septic arthritis]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1150</guid>
		<description><![CDATA[A total of 119 patients were studied. Their mean age was 7.9±5.6 years. Sixty-eight (57.1%) of them were males and 51 (42.9%) were females, giving a male-female ratio of 1.3:1 As shown in Table 1, among 78 patients whose genotype were determined, 49 (62.8%) had hemoglobin genotype AA (HbAA) and 16 (20.5%) had HbSS, while [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2009/12/hemoglobinopathy-and-pattern-of-musculoskeletal-infection-in-children-results.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HEMOGLOBINOPATHY AND PATTERN OF MUSCULOSKELETAL INFECTION IN CHILDREN: Patients and Methods</title>
		<link>http://www.advances-in-medicine.com/2009/12/hemoglobinopathy-and-pattern-of-musculoskeletal-infection-in-children-patients-and-methods.html</link>
		<comments>http://www.advances-in-medicine.com/2009/12/hemoglobinopathy-and-pattern-of-musculoskeletal-infection-in-children-patients-and-methods.html#comments</comments>
		<pubDate>Tue, 08 Dec 2009 08:29:51 +0000</pubDate>
		<dc:creator>James</dc:creator>
				<category><![CDATA[HIV]]></category>
		<category><![CDATA[bacteria]]></category>
		<category><![CDATA[Children]]></category>
		<category><![CDATA[hemoglobinopathy]]></category>
		<category><![CDATA[infection]]></category>
		<category><![CDATA[osteomyelitis]]></category>
		<category><![CDATA[pyomyositis]]></category>
		<category><![CDATA[septic arthritis]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=1148</guid>
		<description><![CDATA[This study was carried out at the Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria. All pediatric and adolescent patients admitted between January 1996 and December 2002 were identified from the admission records of the orthopedic and pediatric services. These were compared with the central medical records to ensure completeness of identification. All patients with bone [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2009/12/hemoglobinopathy-and-pattern-of-musculoskeletal-infection-in-children-patients-and-methods.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

